ValuEngine Downgrades OraSure Technologies, Inc. (OSUR) to Hold

OraSure Technologies, Inc. (NASDAQ:OSUR) was downgraded by equities research analysts at ValuEngine from a “buy” rating to a “hold” rating in a research report issued on Thursday.

Other equities research analysts also recently issued reports about the stock. BidaskClub downgraded shares of OraSure Technologies from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 24th. Canaccord Genuity boosted their price target on shares of OraSure Technologies from $21.00 to $22.00 and gave the company a “buy” rating in a research note on Thursday, August 3rd. Jefferies Group LLC reissued a “buy” rating and issued a $20.00 price target on shares of OraSure Technologies in a research note on Tuesday, September 12th. Finally, Zacks Investment Research raised shares of OraSure Technologies from a “hold” rating to a “buy” rating and set a $24.00 price target on the stock in a research note on Saturday, September 9th. Three analysts have rated the stock with a hold rating and five have given a buy rating to the company. The stock has an average rating of “Buy” and an average target price of $18.21.

OraSure Technologies (NASDAQ:OSUR) last released its quarterly earnings results on Wednesday, November 1st. The medical instruments supplier reported $0.09 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.09. The business had revenue of $42.30 million for the quarter, compared to the consensus estimate of $40.87 million. OraSure Technologies had a net margin of 20.48% and a return on equity of 14.82%. The business’s revenue was up 31.0% on a year-over-year basis. During the same period in the previous year, the firm earned $0.11 EPS.

TRADEMARK VIOLATION NOTICE: “ValuEngine Downgrades OraSure Technologies, Inc. (OSUR) to Hold” was posted by Community Financial News and is the sole property of of Community Financial News. If you are accessing this article on another website, it was stolen and reposted in violation of international copyright & trademark legislation. The legal version of this article can be accessed at https://www.com-unik.info/2017/11/02/valuengine-downgrades-orasure-technologies-inc-osur-to-hold.html.

In related news, CEO Douglas A. Michels sold 25,000 shares of OraSure Technologies stock in a transaction that occurred on Friday, September 29th. The shares were sold at an average price of $22.55, for a total value of $563,750.00. Following the completion of the transaction, the chief executive officer now owns 743,058 shares in the company, valued at $16,755,957.90. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Ronald H. Spair sold 510,112 shares of OraSure Technologies stock in a transaction that occurred on Monday, August 7th. The shares were sold at an average price of $20.66, for a total transaction of $10,538,913.92. Following the completion of the transaction, the chief financial officer now owns 208,606 shares of the company’s stock, valued at approximately $4,309,799.96. The disclosure for this sale can be found here. Insiders sold 717,601 shares of company stock valued at $14,977,398 in the last 90 days. Company insiders own 6.40% of the company’s stock.

Several hedge funds have recently made changes to their positions in OSUR. UBS Asset Management Americas Inc. grew its holdings in shares of OraSure Technologies by 43.5% in the first quarter. UBS Asset Management Americas Inc. now owns 30,996 shares of the medical instruments supplier’s stock valued at $401,000 after purchasing an additional 9,400 shares in the last quarter. Parametric Portfolio Associates LLC grew its holdings in shares of OraSure Technologies by 103.1% in the first quarter. Parametric Portfolio Associates LLC now owns 178,035 shares of the medical instruments supplier’s stock valued at $2,302,000 after purchasing an additional 90,361 shares in the last quarter. Victory Capital Management Inc. acquired a new position in shares of OraSure Technologies in the first quarter valued at approximately $100,000. American International Group Inc. grew its holdings in shares of OraSure Technologies by 7.1% in the first quarter. American International Group Inc. now owns 33,373 shares of the medical instruments supplier’s stock valued at $432,000 after purchasing an additional 2,203 shares in the last quarter. Finally, OppenheimerFunds Inc. acquired a new position in shares of OraSure Technologies in the first quarter valued at approximately $824,000. Hedge funds and other institutional investors own 92.88% of the company’s stock.

OraSure Technologies Company Profile

OraSure Technologies, Inc (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types.

Analyst Recommendations for OraSure Technologies (NASDAQ:OSUR)

What are top analysts saying about OraSure Technologies Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for OraSure Technologies Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit